Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.43
+0.43
(+0.34%)
After-Hours: 20:00
Moderna Accounts Receivable (Quarterly): 137.00M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 137.00M |
December 31, 2023 | 892.00M |
September 30, 2023 | 1.866B |
June 30, 2023 | 232.00M |
March 31, 2023 | 1.113B |
December 31, 2022 | 1.385B |
September 30, 2022 | 2.695B |
June 30, 2022 | 2.691B |
March 31, 2022 | 3.173B |
December 31, 2021 | 3.175B |
September 30, 2021 | 3.142B |
June 30, 2021 | 2.02B |
Date | Value |
---|---|
March 31, 2021 | 3.22B |
December 31, 2020 | 1.391B |
September 30, 2020 | 203.44M |
June 30, 2020 | 50.34M |
March 31, 2020 | 10.50M |
December 31, 2019 | 9.462M |
September 30, 2019 | 18.12M |
June 30, 2019 | 10.83M |
March 31, 2019 | 17.95M |
December 31, 2018 | 22.67M |
September 30, 2018 | 11.56M |
December 31, 2017 | 15.16M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
9.462M
Minimum
Dec 2019
3.22B
Maximum
Mar 2021
1.372B
Average
1.249B
Median
Accounts Receivable (Quarterly) Benchmarks
Merck & Co Inc | 10.35B |
Pfizer Inc | 11.18B |
Eli Lilly and Co | 7.886B |
Johnson & Johnson | 14.95B |
Novavax Inc | 297.24M |